Investment
Features
FeesSafety
Academy
More
Pluang+

Remington's new LaGrange facility begins production of Model 700 rifles and Model 870 shotguns this fall.

Market News
08 Oct 2026
GlobeNewsWire
View Source
Bullish
Remington's new LaGrange facility begins production of Model 700 rifles and Model 870 shotguns this fall.

Remington Firearms has started manufacturing Model 700 rifles and Model 870 shotguns at its new state-of-the-art facility in LaGrange, Georgia. This marks a key step in expanding production capacity and improving product availability across U.S. retail channels. The new facility combines modern technology with Remington's heritage to enhance quality and consistency. Powell Max Limited, which holds a stake in the company managing Remington, highlights this as a milestone for future growth and broader market reach.

Remington Firearms' new production milestone comes as only 28 of 112 Consumer Cyclical-sector US stocks on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Oct 08, 2026 14:01 WIB: CarMax, Inc (KMX) traded at USD 53.35 with a 1-day change of -3.51% and a typical hold time of 49 days, Five Below Inc (FIVE) at USD 202.99 with a 1-day change of -3.30% and 100% buy order activity, and MakeMyTrip Ltd (MMYT) at USD 44.72 with a 1-day change of +3.02% and a typical hold time of 12 days.

More News

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...

Market News
Bullish
37 minutes ago
Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...

Market News
Bullish
1 hour ago
Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...

Market News
Bearish
2 hours ago
Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...

Market News
Bullish
2 hours ago
U.S. XRP ETFs hold $1.7B in assets with net inflows slowing after a strong late-September surge.

U.S. XRP ETFs hold $1.7B in assets with net inflows slowing after a strong late-September surge.

U.S. spot XRP exchange-traded funds held about $1.697 billion in net assets as of October 6, with combined net inflows of $3.14 million that day. This inflow is significantly lower compared to the $75.6 million recorded during the September 21-25 wee...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App